Hsp90 chaperone has been identified as an attractive pharmacological target to combat malignancy. (Accession no. “type”:”entrez-nucleotide”,”attrs”:”text”:”NM_001017963.2″,”term_id”:”153792589″,”term_text”:”NM_001017963.2″NM_001017963.2), 5-TCCGGTATGAAAGCT TGACAG-3, antisense, 5-CTGGTCCAGATGGGCTTTGTT- 3; GAPDH, (Accession no. “type”:”entrez-nucleotide”,”attrs”:”text”:”NM_002046.3″,”term_id”:”83641890″,”term_text”:”NM_002046.3″NM_002046.3), 5-TGA AGGTCGGTGTGAACGGATTTG- 3, antisense, 5-TGATGGCATGGACTGTGGTCATGA- 3. Quantification of blots was performed using Image J software. Immunoblot analyses Cell lysates were prepared using HEPES lysis buffer (20 mM HEPES, 10 mM… Continue reading Hsp90 chaperone has been identified as an attractive pharmacological target to